TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07284602: Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Sponsor: PureTech · Phase: PHASE3 · Area: IMMUNOLOGY · Target Enrollment: 1100 pts

Competing Trials Overlap

12 Active Trials

Excess Burn Exposure

$15,676,800

Rescue Site Savings

+$10,336,890

Unlock Full NCT07284602 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07284602 Rescue Dossier →